Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Immune Thrombocytopenic Purpura | Treatment Algorithms: Claims Data Analysis | US | 2023
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder that leads to a decrease in platelet production, thus increasing the risk of bleeding. Current therapies for ITP can be broadly…
Hidradenitis Suppurativa | Treatment Algorithms: Claims Data Analysis | US | 2023
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disorder affecting hair follicles. It is characterized by inflamed and swollen lesions that are typically painful and filled with…
Ankylosing Spondylitis | Treatment Algorithms | Claims Data Analysis | US | 2023
Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily involving the sacroiliac joints and the axial skeleton, resulting in chronic back pain and stiffness. The key treatment goals…
Dry and Wet Age-Related Macular Degeneration | Disease Landscape & Forecast | G7 | 2022
The wet age-related macular degeneration (AMD) therapy market has long been dominated by three VEGF inhibitors: Roche / Genentech / Chugai’s Avastin, Roche / Genentech / Novartis’s Lucentis,…
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia | China In-Depth | China | 2022
Of the four subtypes of non-Hodgkin’s lymphoma (NHL), diffuse large B-cell lymphoma (DLBCL) is the most common in China. Rituximab (Roche’s MabThera, biosimilars) continues to dominate China’…
